AHA HCM Clinical Update: 2024 Guideline for Management of Hypertrophic Cardiomyopathy
Release Date:
In this On Demand video, Dr. Steve Ommen and Dr. Carolyn Ho discuss recent updates to the 2024 Guideline for the Management of Hypertrophic Cardiomyopathy (HCM). Watch now to enhance your knowledge on the importance of shared decision-making, the use of cardiac myosin inhibitors to treat symptomatic obstructive HCM, and risk stratification for atrial fibrillation to improve patient outcomes.
AHA HCM Clinical Update: 2024 Guideline for Management of Hypertrophic Cardiomyopathy